	The	The	B-NP	O
	functional	functional	I-NP	O
	domains	domain	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	murine	murine	I-NP	O
	Thy-1	Thy-1	I-NP	O
	gene	gene	I-NP	O
	promoter	promoter	I-NP	O
	.	.	O	O

	The	The	B-NP	O
	Thy-1	Thy-1	I-NP	O
	gene	gene	I-NP	O
	promoter	promoter	I-NP	O
	resembles	resemble	B-VP	O
	a	a	B-NP	O
	``	``	I-NP	O
	housekeeping	housekeeping	I-NP	O
	``	``	I-NP	O
	promoter	promoter	I-NP	O
	in	in	B-PP	O
	that	that	B-NP	O
	it	it	B-NP	O
	is	be	B-VP	O
	located	located	B-ADJP	O
	within	within	B-PP	O
	a	a	B-NP	O
	methylation-free	methylation-free	I-NP	O
	island	island	I-NP	O
	,	,	O	O
	lacks	lack	B-VP	O
	a	a	B-NP	O
	canonical	canonical	I-NP	O
	TATA	TATA	I-NP	O
	box	box	I-NP	O
	,	,	O	O
	and	and	O	O
	displays	display	B-VP	O
	heterogeneity	heterogeneity	B-NP	O
	in	in	B-PP	O
	the	the	B-NP	O
	5'-end	5'-end	I-NP	O
	termini	terminus	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	mRNA	mRNA	I-NP	O
	.	.	O	O

	Using	Use	B-VP	O
	transgenic	transgenic	B-NP	O
	mice	mouse	I-NP	O
	,	,	O	O
	we	we	B-NP	O
	show	show	B-VP	O
	that	that	B-SBAR	O
	this	this	B-NP	O
	promoter	promoter	I-NP	O
	does	do	B-VP	O
	not	not	I-VP	O
	confer	confer	I-VP	O
	any	any	B-NP	O
	tissue	tissue	I-NP	O
	specificity	specificity	I-NP	O
	and	and	O	O
	is	be	B-VP	O
	active	active	B-ADJP	O
	only	only	B-PP	O
	in	in	I-PP	O
	a	a	B-NP	O
	position-dependent	position-dependent	I-NP	O
	manner	manner	I-NP	O
	.	.	O	O

	It	It	B-NP	O
	can	can	B-VP	O
	only	only	I-VP	O
	be	be	I-VP	O
	activated	activate	I-VP	O
	in	in	B-PP	O
	a	a	B-NP	O
	tissue-specific	tissue-specific	I-NP	O
	manner	manner	I-NP	O
	by	by	B-PP	O
	elements	element	B-NP	O
	that	that	B-NP	O
	lie	lie	B-VP	O
	downstream	downstream	B-ADJP	O
	of	of	B-PP	O
	the	the	B-NP	O
	initiation	initiation	I-NP	O
	site	site	I-NP	O
	.	.	O	O

	DNase	DNase	B-NP	O
	I	I	I-NP	O
	and	and	I-NP	O
	gel	gel	I-NP	O
	mobility	mobility	I-NP	O
	shift	shift	I-NP	O
	assays	assay	I-NP	O
	show	show	B-VP	O
	the	the	B-NP	O
	binding	binding	I-NP	O
	of	of	B-PP	O
	a	a	B-NP	O
	number	number	I-NP	O
	of	of	B-PP	O
	nuclear	nuclear	B-NP	O
	factors	factor	I-NP	O
	to	to	B-PP	O
	these	these	B-NP	O
	elements	element	I-NP	O
	,	,	O	O
	including	include	B-PP	O
	Sp1	Sp1	B-NP	O
	and	and	O	O
	CP1	CP1	B-NP	O
	.	.	O	O

	Nondividing	Nondivide	B-VP	O
	macrophages	macrophage	B-NP	O
	from	from	B-PP	O
	normal	normal	B-NP	O
	individuals	individual	I-NP	O
	also	also	B-ADVP	O
	expressed	express	B-VP	O
	1,25	1,25	B-NP	O
	-LRB-	(	O	O
	OH	OH	B-NP	O
	-RRB-	)	O	O
	2D3	2D3	B-NP	O
	receptor	receptor	I-NP	O
	RNA	RNA	I-NP	O
	.	.	O	O

	with	with	B-PP	O
	stimulation	stimulation	B-NP	O
	of	of	B-PP	O
	proliferation	proliferation	B-NP	O
	of	of	B-PP	O
	these	these	B-NP	O
	cells	cell	I-NP	O
	,	,	O	O
	accumulation	accumulation	B-NP	O
	of	of	B-PP	O
	1,25	1,25	B-NP	O
	-LRB-	(	O	O
	OH	OH	B-NP	O
	-RRB-	)	O	O
	2D3	2D3	B-NP	O
	receptor	receptor	I-NP	O
	RNA	RNA	I-NP	O
	increased	increase	B-VP	O
	markedly	markedly	B-ADVP	O
	.	.	O	O

	Half-life	Half-life	B-NP	O
	-LRB-	(	O	O
	t1\/2	t1/2	B-NP	O
	-RRB-	)	O	O
	of	of	B-PP	O
	1,25	1,25	B-NP	O
	-LRB-	(	O	O
	OH	OH	B-NP	O
	-RRB-	)	O	O
	2D3	2D3	B-NP	O
	receptor	receptor	I-NP	O
	RNA	RNA	I-NP	O
	in	in	B-PP	O
	T	T	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	was	be	B-VP	O
	short	short	B-ADJP	O
	-LRB-	(	O	O
	1	1	B-NP	O
	hour	hour	I-NP	O
	-RRB-	)	O	O
	as	as	B-SBAR	O
	determined	determine	B-VP	O
	by	by	B-PP	O
	measuring	measure	B-VP	O
	decay	decay	B-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	message	message	I-NP	O
	after	after	B-PP	O
	addition	addition	B-NP	O
	of	of	B-PP	O
	actinomycin	actinomycin	B-NP	O
	D	D	I-NP	O
	.	.	O	O

	Consistent	Consistent	B-ADJP	O
	with	with	B-PP	O
	this	this	B-NP	O
	short	short	I-NP	O
	t1\/2	t1/2	I-NP	O
	,	,	O	O
	accumulation	accumulation	B-NP	O
	of	of	B-PP	O
	1,25	1,25	B-NP	O
	-LRB-	(	O	O
	OH	OH	B-NP	O
	-RRB-	)	O	O
	2D3	2D3	B-NP	O
	receptor	receptor	I-NP	O
	RNA	RNA	I-NP	O
	increased	increase	B-VP	O
	in	in	B-PP	O
	cells	cell	B-NP	O
	as	as	B-SBAR	O
	their	their	B-NP	O
	protein	protein	I-NP	O
	synthesis	synthesis	I-NP	O
	was	be	B-VP	O
	inhibited	inhibit	I-VP	O
	.	.	O	O

	these	these	B-NP	O
	effects	effect	I-NP	O
	are	be	B-VP	O
	probably	probably	I-VP	B-SPECCUE
	mediated	mediate	I-VP	O
	through	through	B-PP	O
	the	the	B-NP	O
	1,25	1,25	I-NP	O
	-LRB-	(	O	O
	OH	OH	B-NP	O
	-RRB-	)	O	O
	2D3	2D3	B-NP	O
	receptor	receptor	I-NP	O
	.	.	O	O

	We	We	B-NP	O
	examined	examine	B-VP	O
	the	the	B-NP	O
	expression	expression	B-NP	O
	and	and	O	O
	modulation	modulation	B-NP	O
	of	of	B-PP	O
	expression	expression	B-NP	O
	of	of	B-PP	O
	1,25	1,25	B-NP	O
	-LRB-	(	O	O
	OH	OH	B-NP	O
	-RRB-	)	O	O
	2D3	2D3	B-NP	O
	receptor	receptor	I-NP	O
	RNA	RNA	I-NP	O
	in	in	B-PP	O
	various	various	B-NP	O
	proliferating	proliferate	I-NP	O
	and	and	I-NP	O
	nonproliferating	nonproliferating	I-NP	O
	hematopoietic	hematopoietic	I-NP	O
	cells	cell	I-NP	O
	.	.	O	O

	Constitutive	Constitutive	B-NP	O
	expression	expression	I-NP	O
	of	of	B-PP	O
	1,25	1,25	B-NP	O
	-LRB-	(	O	O
	OH	OH	B-NP	O
	-RRB-	)	O	O
	2D3	2D3	B-NP	O
	receptor	receptor	I-NP	O
	RNA	RNA	I-NP	O
	was	be	B-VP	O
	detected	detect	I-VP	O
	in	in	B-PP	O
	various	various	B-NP	O
	kinds	kind	I-NP	O
	of	of	B-PP	O
	hematopoietic	hematopoietic	B-NP	O
	cells	cell	I-NP	O
	,	,	O	O
	including	include	B-PP	O
	macrophages	macrophage	B-NP	O
	and	and	O	O
	activated	activate	B-NP	O
	T	T	I-NP	O
	lymphocytes	lymphocyte	I-NP	O
	,	,	O	O
	as	as	B-CONJP	O
	well	well	I-CONJP	O
	as	as	I-CONJP	O
	in	in	B-PP	O
	cell	cell	B-NP	O
	lines	line	I-NP	O
	KG-1	KG-1	B-NP	O
	-LRB-	(	O	O
	myeloblasts	myeloblast	B-NP	O
	-RRB-	)	O	O
	,	,	O	O
	HL-60	HL-60	B-NP	O
	-LRB-	(	O	O
	promyelocytes	promyelocyte	B-NP	O
	-RRB-	)	O	O
	,	,	O	O
	ML-3	ML-3	B-NP	O
	-LRB-	(	O	O
	myelomonoblasts	myelomonoblast	B-NP	O
	-RRB-	)	O	O
	,	,	O	O
	U937	U937	B-NP	O
	,	,	O	O
	THP-1	THP-1	B-NP	O
	-LRB-	(	O	O
	monoblasts	monoblast	B-NP	O
	-RRB-	)	O	O
	,	,	O	O
	K562	K562	B-NP	O
	-LRB-	(	O	O
	erythroblasts	erythroblast	B-NP	O
	-RRB-	)	O	O
	,	,	O	O
	and	and	O	O
	S-LB1	S-LB1	B-NP	O
	-LRB-	(	O	O
	HTLV-1-transfected	HTLV-1-transfected	B-NP	O
	T	T	I-NP	O
	lymphocytes	lymphocyte	I-NP	O
	-RRB-	)	O	O
	.	.	O	O

	Immune	Immune	B-NP	O
	response	response	I-NP	O
	of	of	B-PP	O
	peripheral	peripheral	B-NP	O
	blood	blood	I-NP	O
	mononuclear	mononuclear	I-NP	O
	cells	cell	I-NP	O
	to	to	B-PP	O
	HBx-antigen	HBx-antigen	B-NP	O
	of	of	B-PP	O
	hepatitis	hepatitis	B-NP	O
	B	B	I-NP	O
	virus	virus	I-NP	O
	.	.	O	O

	CD3-epsilon	CD3-epsilon	B-NP	O
	gene	gene	I-NP	O
	expression	expression	I-NP	O
	is	be	B-VP	O
	confined	confine	I-VP	O
	to	to	B-PP	O
	the	the	B-NP	O
	T	T	I-NP	O
	cell	cell	I-NP	O
	lineage	lineage	I-NP	O
	.	.	O	O

	In	In	B-PP	O
	a	a	B-NP	O
	panel	panel	I-NP	O
	of	of	B-PP	O
	human	human	B-NP	O
	cell	cell	I-NP	O
	lines	line	I-NP	O
	,	,	O	O
	TCF-1	TCF-1	B-NP	O
	expression	expression	I-NP	O
	was	be	B-VP	O
	restricted	restricted	B-ADJP	O
	to	to	B-PP	O
	T	T	B-NP	O
	lineage	lineage	I-NP	O
	cells	cell	I-NP	O
	.	.	O	O

	Finally	Finally	B-ADVP	O
	we	we	B-NP	O
	explored	explore	B-VP	O
	the	the	B-NP	O
	possible	possible	I-NP	B-SPECCUE
	role	role	I-NP	O
	of	of	B-PP	O
	5-hydroxyeicosatetraenoic	5-hydroxyeicosatetraenoic	B-NP	O
	acid	acid	I-NP	O
	as	as	B-PP	O
	a	a	B-NP	O
	regulator	regulator	I-NP	O
	of	of	B-PP	O
	arachidonic	arachidonic	B-NP	O
	acid	acid	I-NP	O
	liberation	liberation	I-NP	O
	demonstrating	demonstrate	B-VP	O
	that	that	B-SBAR	O
	endogenous	endogenous	B-NP	O
	5-lipoxygenase	5-lipoxygenase	I-NP	O
	activity	activity	I-NP	O
	modulates	modulate	B-VP	O
	platelet-activating	platelet-activating	B-NP	O
	factor	factor	I-NP	O
	induced	induced	B-NP	O
	arachidonic	arachidonic	I-NP	O
	acid	acid	I-NP	O
	release	release	I-NP	O
	perhaps	perhaps	B-ADVP	B-SPECCUE
	acting	act	B-VP	O
	at	at	B-PP	O
	the	the	B-NP	O
	level	level	I-NP	O
	of	of	B-PP	O
	phospholipase	phospholipase	B-NP	O
	A2	A2	I-NP	O
	.	.	O	O

	Studies	Study	B-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	actions	action	I-NP	O
	of	of	B-PP	O
	platelet-activating	platelet-activating	B-NP	O
	factor	factor	I-NP	O
	have	have	B-VP	O
	centered	center	I-VP	O
	mainly	mainly	B-ADVP	O
	around	around	B-PP	O
	neutrophils	neutrophil	B-NP	O
	,	,	O	O
	monocytes	monocyte	B-NP	O
	,	,	O	O
	and	and	O	O
	platelets	platelet	B-NP	O
	.	.	O	O

	Vitamin	Vitamin	B-NP	O
	D	D	I-NP	O
	receptor	receptor	I-NP	O
	expression	expression	I-NP	O
	in	in	B-PP	O
	human	human	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	.	.	O	O

	The	The	B-NP	O
	receptor	receptor	I-NP	O
	from	from	B-PP	O
	OKT3	OKT3	B-NP	O
	and	and	I-NP	O
	OKT3	OKT3	I-NP	O
	+	+	O	O
	phorbol	phorbol	B-NP	O
	myristate	myristate	I-NP	O
	acetate-activated	acetate-activated	B-VP	O
	lymphocytes	lymphocyte	B-NP	O
	exhibited	exhibit	B-VP	O
	decreased	decrease	B-NP	O
	binding	binding	I-NP	O
	to	to	B-PP	O
	DNA-cellulose	DNA-cellulose	B-NP	O
	compared	compare	B-VP	O
	to	to	B-PP	O
	PHA-activated	PHA-activated	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	.	.	O	O

	Finally	Finally	B-ADVP	O
	,	,	O	O
	RNA	RNA	B-NP	O
	from	from	B-PP	O
	activated	activate	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	was	be	B-VP	O
	amplified	amplify	I-VP	O
	by	by	B-PP	O
	polymerase	polymerase	B-NP	O
	chain	chain	I-NP	O
	reaction	reaction	I-NP	O
	using	use	B-VP	O
	oligonucleotide	oligonucleotide	B-NP	O
	primers	primer	I-NP	O
	flanking	flank	B-VP	O
	the	the	B-NP	O
	196	196	I-NP	O
	base	base	I-NP	O
	pair	pair	I-NP	O
	long	long	I-NP	O
	region	region	I-NP	O
	encoding	encode	B-VP	O
	the	the	B-NP	O
	DNA-binding	DNA-binding	I-NP	O
	domain	domain	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	human	human	I-NP	O
	intestinal	intestinal	I-NP	O
	receptor	receptor	I-NP	O
	.	.	O	O

	The	The	B-NP	O
	amplified	amplify	I-NP	O
	product	product	I-NP	O
	showed	show	B-VP	O
	an	an	B-NP	O
	identical	identical	I-NP	O
	nucleotide	nucleotide	I-NP	O
	sequence	sequence	I-NP	O
	to	to	B-PP	O
	the	the	B-NP	O
	DNA-binding	DNA-binding	I-NP	O
	domain	domain	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	human	human	I-NP	O
	intestinal	intestinal	I-NP	O
	receptor	receptor	I-NP	O
	.	.	O	O

	Role	Role	B-NP	O
	for	for	B-PP	O
	the	the	B-NP	O
	Epstein-Barr	Epstein-Barr	I-NP	O
	virus	virus	I-NP	O
	nuclear	nuclear	I-NP	O
	antigen	antigen	I-NP	O
	2	2	I-NP	O
	in	in	B-PP	O
	viral	viral	B-NP	O
	promoter	promoter	I-NP	O
	switching	switching	I-NP	O
	during	during	B-PP	O
	initial	initial	B-NP	O
	stages	stage	I-NP	O
	of	of	B-PP	O
	infection	infection	B-NP	O
	.	.	O	O

	These	These	B-NP	O
	studies	study	I-NP	O
	have	have	B-VP	O
	been	be	I-VP	O
	extended	extend	I-VP	O
	to	to	I-VP	O
	show	show	I-VP	O
	that	that	B-SBAR	O
	-LRB-	(	B-LST	O
	i	i	I-LST	O
	-RRB-	)	O	O
	a	a	B-NP	O
	mutant	mutant	I-NP	O
	EBV	EBV	I-NP	O
	strain	strain	I-NP	O
	lacking	lack	B-VP	O
	the	the	B-NP	O
	gene	gene	I-NP	O
	encoding	encode	B-VP	O
	EBNA	EBNA	B-NP	O
	2	2	I-NP	O
	fails	fail	B-VP	O
	to	to	I-VP	O
	switch	switch	I-VP	O
	from	from	B-PP	O
	Wp	Wp	B-NP	O
	to	to	B-PP	O
	Cp	Cp	B-NP	O
	usage	usage	I-NP	O
	in	in	B-PP	O
	primary	primary	B-NP	O
	B	B	I-NP	O
	lymphocytes	lymphocyte	I-NP	O
	,	,	O	O
	although	although	B-SBAR	O
	the	the	B-NP	O
	virus	virus	I-NP	O
	contains	contain	B-VP	O
	a	a	B-NP	O
	functional	functional	I-NP	O
	Cp	Cp	I-NP	O
	;	;	O	O
	-LRB-	(	B-LST	O
	ii	ii	I-LST	O
	-RRB-	)	O	O
	a	a	B-NP	O
	region	region	I-NP	O
	from	from	B-PP	O
	-429	-429	B-NP	O
	to	to	I-NP	O
	-245	-245	I-NP	O
	base	base	I-NP	O
	pairs	pair	I-NP	O
	upstream	upstream	B-ADJP	O
	of	of	B-PP	O
	Cp	Cp	B-NP	O
	is	be	B-VP	O
	essential	essential	B-ADJP	O
	for	for	B-PP	O
	Cp	Cp	B-NP	O
	activity	activity	I-NP	O
	in	in	B-PP	O
	B	B	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	,	,	O	O
	but	but	O	O
	only	only	B-PP	O
	in	in	I-PP	O
	the	the	B-NP	O
	context	context	I-NP	O
	of	of	B-PP	O
	upstream	upstream	B-NP	O
	and	and	I-NP	O
	downstream	downstream	I-NP	O
	sequences	sequence	I-NP	O
	;	;	O	O
	-LRB-	(	B-LST	O
	iii	iii	I-LST	O
	-RRB-	)	O	O
	this	this	B-NP	O
	region	region	I-NP	O
	contains	contain	B-VP	O
	an	an	B-NP	O
	EBNA	EBNA	I-NP	O
	2-dependent	2-dependent	I-NP	O
	enhancer	enhancer	I-NP	O
	;	;	O	O
	and	and	O	O
	-LRB-	(	B-LST	O
	iv	iv	I-LST	O
	-RRB-	)	O	O
	DNase	DNase	B-NP	O
	I	I	I-NP	O
	protection	protection	I-NP	O
	employing	employ	B-VP	O
	nuclear	nuclear	B-NP	O
	extracts	extract	I-NP	O
	from	from	B-PP	O
	B	B	B-NP	O
	and	and	O	O
	T	T	B-NP	O
	lymphocytes	lymphocyte	B-NP	O
	revealed	reveal	B-VP	O
	a	a	B-NP	O
	B-cell-specific	B-cell-specific	I-NP	O
	footprint	footprint	I-NP	O
	in	in	B-PP	O
	the	the	B-NP	O
	region	region	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	EBNA	EBNA	I-NP	O
	2-dependent	2-dependent	I-NP	O
	enhancer	enhancer	I-NP	O
	.	.	O	O

	Okadaic	Okadaic	B-NP	O
	acid	acid	I-NP	O
	was	be	B-VP	O
	found	find	I-VP	O
	to	to	I-VP	O
	be	be	I-VP	O
	a	a	B-NP	O
	potent	potent	I-NP	O
	inducer	inducer	I-NP	O
	of	of	B-PP	O
	AP1	AP1	B-NP	O
	.	.	O	O

	Upon	Upon	B-PP	O
	functional	functional	B-NP	O
	activation	activation	I-NP	O
	of	of	B-PP	O
	granulocytes	granulocyte	B-NP	O
	by	by	B-PP	O
	4	4	B-NP	O
	beta-phorbol	beta-phorbol	I-NP	O
	12-myristate	12-myristate	I-NP	O
	13-acetate	13-acetate	I-NP	O
	-LRB-	(	O	O
	PMA	PMA	B-NP	O
	-RRB-	)	O	O
	,	,	O	O
	the	the	B-NP	O
	levels	level	I-NP	O
	of	of	B-PP	O
	c-jun	c-jun	B-NP	O
	,	,	O	O
	jun	jun	B-NP	O
	B	B	I-NP	O
	and	and	O	O
	jun	jun	B-NP	O
	D	D	I-NP	O
	transcripts	transcript	B-NP	O
	were	be	B-VP	O
	increased	increase	I-VP	O
	.	.	O	O

	Circadian	Circadian	B-NP	O
	rhythm	rhythm	I-NP	O
	in	in	B-PP	O
	glucocorticoid	glucocorticoid	B-NP	O
	receptor	receptor	I-NP	O
	-LRB-	(	O	O
	GR	GR	B-NP	O
	-RRB-	)	O	O
	was	be	B-VP	O
	studied	study	I-VP	O
	in	in	B-PP	O
	the	the	B-NP	O
	rat	rat	I-NP	O
	liver	liver	I-NP	O
	and	and	O	O
	human	human	B-ADJP	O
	peripheral	peripheral	I-ADJP	O
	leukocytes	leukocyte	B-NP	O
	.	.	O	O

	For	For	B-PP	O
	rats	rat	B-NP	O
	exposed	expose	B-VP	O
	to	to	B-PP	O
	a	a	B-NP	O
	natural	natural	I-NP	O
	environmental	environmental	I-NP	O
	photic	photic	I-NP	O
	cycle	cycle	I-NP	O
	or	or	O	O
	a	a	B-NP	O
	12L	12L	I-NP	O
	:	:	I-NP	O
	12D	12D	I-NP	O
	artificial	artificial	I-NP	O
	light	light	I-NP	O
	regime	regime	I-NP	O
	,	,	O	O
	peak	peak	B-NP	O
	values	value	I-NP	O
	of	of	B-PP	O
	hepatic	hepatic	B-NP	O
	GR	GR	I-NP	O
	were	be	B-VP	O
	detected	detect	I-VP	O
	between	between	B-PP	O
	23	23	B-NP	O
	:	:	O	O
	00	00	B-NP	O
	and	and	I-NP	O
	02	02	I-NP	O
	:	:	O	O
	00	00	B-NP	O
	h	h	I-NP	O
	.	.	O	O

	For	For	B-PP	O
	apoplexic	apoplexic	B-NP	O
	patients	patient	I-NP	O
	with	with	B-PP	O
	lesions	lesion	B-NP	O
	localized	localized	B-ADJP	O
	to	to	B-PP	O
	the	the	B-NP	O
	base	base	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	brain	brain	I-NP	O
	as	as	B-SBAR	O
	indicated	indicate	B-VP	O
	by	by	B-PP	O
	computerized	computerize	B-NP	O
	tomography	tomography	I-NP	O
	,	,	O	O
	the	the	B-NP	O
	diurnal	diurnal	I-NP	O
	variation	variation	I-NP	O
	of	of	B-PP	O
	GR	GR	B-NP	O
	was	be	B-VP	O
	abolished	abolish	I-VP	O
	.	.	O	O

	Thus	Thus	B-ADVP	O
	,	,	O	O
	we	we	B-NP	O
	postulated	postulate	B-VP	B-SPECCUE
	that	that	B-SBAR	O
	the	the	B-NP	O
	circadian	circadian	I-NP	O
	modification	modification	I-NP	O
	of	of	B-PP	O
	GR	GR	B-NP	O
	was	be	B-VP	O
	independent	independent	B-ADJP	O
	of	of	B-PP	O
	the	the	B-NP	O
	diurnal	diurnal	I-NP	O
	fluctuations	fluctuation	I-NP	O
	in	in	B-PP	O
	plasma	plasma	B-NP	O
	cortisol	cortisol	I-NP	O
	level	level	I-NP	O
	or	or	O	O
	the	the	B-NP	O
	circadian	circadian	I-NP	O
	variations	variation	I-NP	O
	in	in	B-PP	O
	environmental	environmental	B-NP	O
	lighting	lighting	I-NP	O
	and	and	O	O
	that	that	B-SBAR	O
	the	the	B-NP	O
	rhythmicity	rhythmicity	I-NP	O
	might	might	B-VP	O
	be	be	I-VP	O
	regulated	regulate	I-VP	O
	by	by	B-PP	O
	the	the	B-NP	O
	'	'	I-NP	O
	circadian	circadian	I-NP	O
	pacemaker	pacemaker	I-NP	O
	'	'	O	O
	located	located	B-ADJP	O
	in	in	B-PP	O
	the	the	B-NP	O
	human	human	I-NP	O
	basal	basal	I-NP	O
	brain	brain	I-NP	O
	.	.	O	O

	Transforming	Transform	B-NP	O
	growth	growth	I-NP	O
	factor-beta	factor-beta	I-NP	O
	-LRB-	(	O	O
	TGF-beta	TGF-beta	B-NP	O
	-RRB-	)	O	O
	inhibits	inhibit	B-VP	O
	B	B	B-NP	O
	cell	cell	I-NP	O
	Ig	Ig	I-NP	O
	secretion	secretion	I-NP	O
	and	and	O	O
	reduces	reduce	B-VP	O
	B	B	B-NP	O
	cell	cell	I-NP	O
	membrane	membrane	I-NP	O
	Ig	Ig	I-NP	O
	expression	expression	I-NP	O
	.	.	O	O

	A	A	B-NP	O
	less	less	I-NP	O
	pronounced	pronounced	I-NP	O
	reduction	reduction	I-NP	O
	in	in	B-PP	O
	lambda	lambda	B-NP	O
	L	L	I-NP	O
	chain	chain	I-NP	O
	and	and	O	O
	microH	microH	B-NP	O
	chain	chain	I-NP	O
	was	be	B-VP	O
	also	also	I-VP	O
	noted	note	I-VP	O
	.	.	O	O

	Furthermore	Furthermore	B-ADVP	O
	,	,	O	O
	a	a	B-NP	O
	significant	significant	I-NP	O
	decrease	decrease	I-NP	O
	in	in	B-PP	O
	the	the	B-NP	O
	switch	switch	I-NP	O
	from	from	B-PP	O
	the	the	B-NP	O
	membrane	membrane	I-NP	O
	forms	form	I-NP	O
	of	of	B-PP	O
	mu	mu	B-NP	O
	and	and	O	O
	gamma	gamma	B-NP	O
	to	to	B-PP	O
	their	their	B-NP	O
	respective	respective	I-NP	O
	secreted	secreted	I-NP	O
	forms	form	I-NP	O
	was	be	B-VP	O
	noted	note	I-VP	O
	in	in	B-PP	O
	the	the	I-PP	O
	presence	presence	I-PP	O
	of	of	I-PP	O
	TGF-beta	TGF-beta	B-NP	O
	.	.	O	O

	The	The	B-NP	O
	production	production	I-NP	O
	of	of	B-PP	O
	human	human	B-NP	O
	immunodeficiency	immunodeficiency	I-NP	O
	virus	virus	I-NP	O
	type	type	I-NP	O
	1	1	I-NP	O
	-LRB-	(	O	O
	HIV-1	HIV-1	B-NP	O
	-RRB-	)	O	O
	progeny	progeny	B-NP	O
	was	be	B-VP	O
	followed	follow	I-VP	O
	in	in	B-PP	O
	the	the	B-NP	O
	U937	U937	I-NP	O
	promonocytic	promonocytic	I-NP	O
	cell	cell	I-NP	O
	line	line	I-NP	O
	after	after	B-PP	O
	stimulation	stimulation	B-NP	O
	either	either	B-PP	O
	with	with	I-PP	O
	retinoic	retinoic	B-NP	O
	acid	acid	I-NP	O
	or	or	O	O
	PMA	PMA	B-NP	O
	,	,	O	O
	and	and	O	O
	in	in	B-PP	O
	purified	purify	B-NP	O
	human	human	I-NP	O
	monocytes	monocyte	B-NP	O
	and	and	O	O
	macrophages	macrophage	B-NP	O
	.	.	O	O

	Positive	Positive	B-NP	O
	and	and	I-NP	O
	negative	negative	I-NP	O
	regulation	regulation	I-NP	O
	of	of	B-PP	O
	immunoglobulin	immunoglobulin	B-NP	O
	gene	gene	I-NP	O
	expression	expression	I-NP	O
	by	by	B-PP	O
	a	a	B-NP	O
	novel	novel	I-NP	O
	B-cell-specific	B-cell-specific	I-NP	O
	enhancer	enhancer	I-NP	O
	element	element	I-NP	O
	.	.	O	O

	Gel	Gel	B-NP	O
	mobility	mobility	I-NP	O
	shift	shift	I-NP	O
	assays	assay	I-NP	O
	using	use	B-VP	O
	a	a	B-NP	O
	synthetic	synthetic	I-NP	O
	E6	E6	I-NP	O
	motif	motif	I-NP	O
	detected	detect	B-VP	O
	a	a	B-NP	O
	B-cell-specific	B-cell-specific	I-NP	O
	complex	complex	I-NP	O
	in	in	B-PP	O
	addition	addition	B-NP	O
	to	to	B-PP	O
	a	a	B-NP	O
	ubiquitous	ubiquitous	I-NP	O
	band	band	I-NP	O
	found	find	B-VP	O
	also	also	B-ADVP	O
	in	in	B-PP	O
	T	T	B-NP	O
	cells	cell	I-NP	O
	and	and	O	O
	HeLa	HeLa	B-NP	O
	cells	cell	I-NP	O
	.	.	O	O

	Furthermore	Furthermore	B-ADVP	O
	,	,	O	O
	a	a	B-NP	O
	mutant	mutant	I-NP	O
	E6	E6	I-NP	O
	motif	motif	I-NP	O
	lost	lose	B-VP	O
	both	both	O	O
	in	in	B-NP	O
	vitro	vitro	I-NP	O
	binding	binding	I-NP	O
	activity	activity	I-NP	O
	and	and	B-PP	O
	in	in	B-NP	O
	vivo	vivo	I-NP	O
	enhancer	enhancer	I-NP	O
	activity	activity	I-NP	O
	.	.	O	O

	Neither	Neither	O	O
	deletion	deletion	B-NP	O
	of	of	B-PP	O
	NF	NF	B-NP	O
	kappa	kappa	I-NP	O
	B	B	I-NP	O
	nor	nor	O	O
	deletion	deletion	B-NP	O
	of	of	B-PP	O
	NFAT-1	NFAT-1	B-NP	O
	decreased	decrease	B-VP	O
	activation	activation	B-NP	O
	of	of	B-PP	O
	viral	viral	B-NP	O
	replication	replication	I-NP	O
	by	by	B-PP	O
	phorbol	phorbol	B-NP	O
	ester	ester	I-NP	O
	.	.	O	O

	These	These	B-NP	O
	results	result	I-NP	O
	identify	identify	B-VP	O
	TCF-1	TCF-1	B-NP	O
	as	as	B-PP	O
	a	a	B-NP	O
	T	T	I-NP	O
	cell-specific	cell-specific	I-NP	O
	transcription	transcription	I-NP	O
	factor	factor	I-NP	O
	,	,	O	O
	which	which	B-NP	O
	might	might	B-VP	B-SPECCUE
	play	play	I-VP	O
	a	a	B-NP	O
	role	role	I-NP	O
	in	in	B-PP	O
	the	the	B-NP	O
	establishment	establishment	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	mature	mature	I-NP	O
	T	T	I-NP	O
	cell	cell	I-NP	O
	phenotype	phenotype	I-NP	O
	.	.	O	O

	Activation	Activation	B-NP	O
	of	of	B-PP	O
	T	T	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	induces	induce	B-VP	O
	an	an	B-NP	O
	NF-kappa	NF-kappa	I-NP	O
	B-like	B-like	I-NP	O
	binding	binding	I-NP	O
	activity	activity	I-NP	O
	to	to	B-PP	O
	the	the	B-NP	O
	B2	B2	I-NP	O
	site	site	I-NP	O
	,	,	O	O
	concomitant	concomitant	B-ADJP	O
	with	with	B-PP	O
	activation	activation	B-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	proenkephalin	proenkephalin	I-NP	O
	promoter	promoter	I-NP	O
	.	.	O	O

	Thus	Thus	B-ADVP	O
	,	,	O	O
	it	it	B-NP	O
	appears	appear	B-VP	B-SPECCUE
	that	that	B-SBAR	O
	the	the	B-NP	O
	T-cell-specific	T-cell-specific	I-NP	O
	activation	activation	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	proenkephalin	proenkephalin	I-NP	O
	promoter	promoter	I-NP	O
	is	be	B-VP	O
	mediated	mediate	I-VP	O
	by	by	B-PP	O
	NF-kappa	NF-kappa	B-NP	O
	B	B	I-NP	O
	.	.	O	O

	However	However	B-ADVP	O
	,	,	O	O
	as	as	B-SBAR	O
	NF-kappa	NF-kappa	B-NP	O
	B	B	I-NP	O
	is	be	B-VP	O
	ubiquitous	ubiquitous	B-ADJP	O
	and	and	O	O
	the	the	B-NP	O
	transcriptional	transcriptional	I-NP	O
	activation	activation	I-NP	O
	through	through	B-PP	O
	the	the	B-NP	O
	B2	B2	I-NP	O
	site	site	I-NP	O
	is	be	B-VP	O
	T	T	B-NP	O
	cell	cell	I-NP	O
	specific	specific	B-ADJP	O
	,	,	O	O
	yet	yet	B-NP	O
	another	another	I-NP	O
	T-cell-specific	T-cell-specific	I-NP	O
	factor	factor	I-NP	O
	which	which	B-NP	O
	synergizes	synergize	B-VP	O
	with	with	B-PP	O
	NF-kappa	NF-kappa	B-NP	O
	B	B	I-NP	O
	should	should	B-VP	B-SPECCUE
	be	be	I-VP	O
	considered	consider	I-VP	O
	.	.	O	O

	Three	Three	B-NP	O
	molecular	molecular	I-NP	O
	clones	clone	I-NP	O
	of	of	B-PP	O
	HIV-1	HIV-1	B-NP	O
	,	,	O	O
	derived	derive	B-VP	O
	from	from	B-PP	O
	a	a	B-NP	O
	single	single	I-NP	O
	isolate	isolate	I-NP	O
	-LRB-	(	O	O
	AL1	AL1	B-NP	O
	-RRB-	)	O	O
	,	,	O	O
	exhibited	exhibit	B-VP	O
	distinct	distinct	B-NP	O
	replicative	replicative	I-NP	O
	and	and	I-NP	O
	cytopathic	cytopathic	I-NP	O
	properties	property	I-NP	O
	during	during	B-PP	O
	propagation	propagation	B-NP	O
	in	in	B-PP	O
	a	a	B-NP	O
	human	human	I-NP	O
	T	T	I-NP	O
	cell	cell	I-NP	O
	line	line	I-NP	O
	.	.	O	O

	To	To	B-VP	O
	dissect	dissect	I-VP	O
	the	the	B-NP	O
	molecular	molecular	I-NP	O
	basis	basis	I-NP	O
	for	for	B-PP	O
	the	the	B-NP	O
	unusual	unusual	I-NP	O
	persistent	persistent	I-NP	O
	expression	expression	I-NP	O
	of	of	B-PP	O
	the	the	O	O
	IL-2	IL-2	B-NP	O
	and	and	O	O
	IL-2-R	IL-2-R	B-NP	O
	alpha	alpha	I-NP	O
	genes	gene	B-NP	O
	in	in	B-PP	O
	these	these	B-NP	O
	IARC	IARC	I-NP	O
	301	301	I-NP	O
	T	T	I-NP	O
	cells	cell	I-NP	O
	,	,	O	O
	we	we	B-NP	O
	have	have	B-VP	O
	analyzed	analyze	I-VP	O
	the	the	B-NP	O
	interactions	interaction	I-NP	O
	of	of	B-PP	O
	constitutively	constitutively	B-NP	O
	expressed	express	I-NP	O
	nuclear	nuclear	I-NP	O
	proteins	protein	I-NP	O
	with	with	B-PP	O
	the	the	B-NP	O
	5	5	I-NP	O
	'	'	I-NP	O
	flanking	flanking	I-NP	O
	regions	region	I-NP	O
	of	of	B-PP	O
	the	the	O	O
	IL-2	IL-2	B-NP	O
	and	and	O	O
	IL-2-R	IL-2-R	B-NP	O
	alpha	alpha	I-NP	O
	genes	gene	B-NP	O
	using	use	B-VP	O
	both	both	O	O
	DNase	DNase	B-NP	O
	I	I	I-NP	O
	footprinting	footprinting	I-NP	O
	and	and	O	O
	gel	gel	B-NP	O
	retardation	retardation	I-NP	O
	techniques	technique	I-NP	O
	.	.	O	O

	Two	Two	B-NP	O
	proteins	protein	I-NP	O
	binding	bind	B-VP	O
	the	the	B-NP	O
	kappa	kappa	I-NP	O
	B	B	I-NP	O
	sequence	sequence	I-NP	O
	,	,	O	O
	NF-kappa	NF-kappa	B-NP	O
	B	B	I-NP	O
	and	and	O	O
	KBF1	KBF1	B-NP	O
	,	,	O	O
	are	be	B-VP	O
	constitutively	constitutively	I-VP	O
	expressed	express	I-VP	O
	in	in	B-PP	O
	IARC	IARC	B-NP	O
	301	301	I-NP	O
	nuclei	nucleus	I-NP	O
	and	and	O	O
	induced	induce	B-VP	O
	by	by	B-PP	O
	PMA	PMA	B-NP	O
	and	and	O	O
	PHA	PHA	B-NP	O
	in	in	B-PP	O
	Jurkat	Jurkat	B-NP	O
	.	.	O	O

	Comparison	Comparison	B-NP	O
	of	of	B-PP	O
	constitutive	constitutive	B-NP	O
	and	and	I-NP	O
	inducible	inducible	I-NP	O
	transcriptional	transcriptional	I-NP	O
	enhancement	enhancement	I-NP	O
	mediated	mediate	B-VP	O
	by	by	B-PP	O
	kappa	kappa	B-NP	O
	B-related	B-related	I-NP	O
	sequences	sequence	I-NP	O
	:	:	O	O
	modulation	modulation	B-NP	O
	of	of	B-PP	O
	activity	activity	B-NP	O
	in	in	B-PP	O
	B	B	B-NP	O
	cells	cell	I-NP	O
	by	by	B-PP	O
	human	human	B-NP	O
	T-cell	T-cell	I-NP	O
	leukemia	leukemia	I-NP	O
	virus	virus	I-NP	O
	type	type	I-NP	O
	I	I	I-NP	O
	tax	tax	I-NP	O
	gene	gene	I-NP	O
	.	.	O	O

	The	The	B-NP	O
	kappa	kappa	I-NP	O
	B	B	I-NP	O
	sequence	sequence	I-NP	O
	-LRB-	(	O	O
	GGGACTTTCC	GGGACTTTCC	B-NP	O
	-RRB-	)	O	O
	binds	bind	B-VP	O
	a	a	B-NP	O
	factor	factor	I-NP	O
	,	,	O	O
	NF-kappa	NF-kappa	B-NP	O
	B	B	I-NP	O
	,	,	O	O
	that	that	B-NP	O
	is	be	B-VP	O
	constitutively	constitutively	I-VP	O
	found	find	I-VP	O
	in	in	B-PP	O
	its	its	B-NP	O
	functional	functional	I-NP	O
	,	,	I-NP	O
	DNA	DNA	I-NP	O
	binding	binding	I-NP	O
	form	form	I-NP	O
	only	only	B-PP	O
	in	in	I-PP	O
	B	B	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	.	.	O	O

	For	For	B-PP	O
	example	example	B-NP	O
	,	,	O	O
	kappa	kappa	B-NP	O
	B-related	B-related	I-NP	O
	sequences	sequence	I-NP	O
	have	have	B-VP	O
	been	be	I-VP	O
	shown	show	I-VP	O
	to	to	I-VP	O
	be	be	I-VP	O
	important	important	B-ADJP	O
	for	for	B-PP	O
	the	the	B-NP	O
	transcription	transcription	I-NP	O
	of	of	B-PP	O
	a	a	B-NP	O
	few	few	I-NP	O
	inducible	inducible	I-NP	O
	genes	gene	I-NP	O
	,	,	O	O
	such	such	B-PP	O
	as	as	I-PP	O
	the	the	B-NP	O
	interleukin	interleukin	I-NP	O
	2	2	I-NP	O
	receptor	receptor	I-NP	O
	alpha-chain	alpha-chain	I-NP	O
	gene	gene	I-NP	O
	and	and	O	O
	the	the	B-NP	O
	beta-interferon	beta-interferon	I-NP	O
	gene	gene	I-NP	O
	.	.	O	O

	However	However	B-ADVP	O
	,	,	O	O
	these	these	B-NP	O
	genes	gene	I-NP	O
	are	be	B-VP	O
	not	not	O	O
	constitutively	constitutively	B-ADJP	O
	active	active	I-ADJP	O
	in	in	B-PP	O
	B	B	B-NP	O
	lymphocytes	lymphocyte	I-NP	O
	,	,	O	O
	suggesting	suggest	B-VP	B-SPECCUE
	that	that	B-SBAR	O
	other	other	B-NP	O
	regulatory	regulatory	I-NP	O
	mechanisms	mechanism	I-NP	O
	must	must	B-VP	O
	play	play	I-VP	O
	a	a	B-NP	O
	role	role	I-NP	O
	in	in	B-PP	O
	determining	determine	B-VP	O
	the	the	B-NP	O
	patterns	pattern	I-NP	O
	of	of	B-PP	O
	expression	expression	B-NP	O
	.	.	O	O

	We	We	B-NP	O
	have	have	B-VP	O
	investigated	investigate	I-VP	O
	the	the	B-NP	O
	constitutive	constitutive	I-NP	O
	and	and	I-NP	O
	inducible	inducible	I-NP	O
	transcriptional	transcriptional	I-NP	O
	activity	activity	I-NP	O
	mediated	mediate	B-VP	O
	by	by	B-PP	O
	five	five	B-NP	O
	kappa	kappa	I-NP	O
	B-related	B-related	I-NP	O
	sequence	sequence	I-NP	O
	elements	element	I-NP	O
	in	in	B-PP	O
	two	two	B-NP	O
	different	different	I-NP	O
	cell	cell	I-NP	O
	types	type	I-NP	O
	.	.	O	O

	We	We	B-NP	O
	show	show	B-VP	O
	that	that	B-SBAR	O
	in	in	B-PP	O
	S194	S194	B-NP	O
	plasma	plasma	I-NP	O
	cells	cell	I-NP	O
	the	the	B-NP	O
	activity	activity	I-NP	O
	of	of	B-PP	O
	each	each	B-NP	O
	element	element	I-NP	O
	correlates	correlate	B-VP	O
	well	well	B-ADVP	O
	with	with	B-PP	O
	the	the	B-NP	O
	relative	relative	I-NP	O
	affinity	affinity	I-NP	O
	of	of	B-PP	O
	B-cell-derived	B-cell-derived	B-NP	O
	NF-kappa	NF-kappa	I-NP	O
	B	B	I-NP	O
	for	for	B-PP	O
	that	that	B-NP	O
	element	element	I-NP	O
	.	.	O	O

	This	This	B-NP	O
	protein-DNA	protein-DNA	I-NP	O
	complex	complex	I-NP	O
	comigrated	comigrate	B-VP	O
	with	with	B-PP	O
	the	the	B-NP	O
	complex	complex	I-NP	O
	obtained	obtain	B-VP	O
	with	with	B-PP	O
	the	the	B-NP	O
	purified	purify	I-NP	O
	human	human	I-NP	O
	p65	p65	I-NP	O
	NF-kappa	NF-kappa	I-NP	O
	B	B	I-NP	O
	subunit	subunit	I-NP	O
	and	and	O	O
	binding	binding	B-NP	O
	was	be	B-VP	O
	inhibited	inhibit	I-VP	O
	by	by	B-PP	O
	I	I	B-NP	O
	kappa	kappa	I-NP	O
	B-alpha	B-alpha	I-NP	O
	and	and	O	O
	-beta	-beta	B-NP	O
	proteins	protein	I-NP	O
	.	.	O	O

	In	In	B-PP	O
	addition	addition	B-NP	O
	,	,	O	O
	the	the	B-NP	O
	65-kD	65-kD	I-NP	O
	protein	protein	I-NP	O
	associated	associate	B-VP	O
	with	with	B-PP	O
	the	the	B-NP	O
	p50	p50	I-NP	O
	subunit	subunit	I-NP	O
	of	of	B-PP	O
	NF-kappa	NF-kappa	B-NP	O
	B	B	I-NP	O
	and	and	O	O
	the	the	B-NP	O
	kappa	kappa	I-NP	O
	B	B	I-NP	O
	probe	probe	I-NP	O
	to	to	B-VP	O
	form	form	I-VP	O
	a	a	B-NP	O
	complex	complex	I-NP	O
	with	with	B-PP	O
	the	the	B-NP	O
	same	same	I-NP	O
	electrophoretic	electrophoretic	I-NP	O
	mobility	mobility	I-NP	O
	as	as	B-PP	O
	the	the	B-NP	O
	NF-kappa	NF-kappa	I-NP	O
	B-DNA	B-DNA	I-NP	O
	complex	complex	I-NP	O
	.	.	O	O

	The	The	B-NP	O
	present	present	I-NP	O
	data	datum	I-NP	O
	,	,	O	O
	along	along	B-ADVP	O
	with	with	B-PP	O
	other	other	B-NP	O
	findings	finding	I-NP	O
	of	of	B-PP	O
	HPA	HPA	B-NP	O
	abnormalities	abnormality	I-NP	O
	in	in	B-PP	O
	PTSD	PTSD	B-NP	O
	,	,	O	O
	support	support	B-VP	O
	the	the	B-NP	O
	possibility	possibility	I-NP	B-SPECCUE
	of	of	B-PP	O
	a	a	B-NP	O
	greater	great	I-NP	O
	negative	negative	I-NP	O
	feedback	feedback	I-NP	O
	sensitivity	sensitivity	I-NP	O
	at	at	B-PP	O
	one	one	B-NP	O
	or	or	I-NP	O
	more	more	I-NP	O
	levels	level	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	HPA	HPA	I-NP	O
	axis	axis	I-NP	O
	.	.	O	O

	Multiple	Multiple	B-NP	O
	Oct2	Oct2	I-NP	O
	isoforms	isoform	I-NP	O
	are	be	B-VP	O
	generated	generate	I-VP	O
	by	by	B-PP	O
	alternative	alternative	B-NP	O
	splicing	splicing	I-NP	O
	.	.	O	O

	Ectopic	Ectopic	B-NP	O
	expression	expression	I-NP	O
	of	of	B-PP	O
	cloned	clone	B-NP	O
	Oct2	Oct2	I-NP	O
	cDNA	cDNA	I-NP	O
	was	be	B-VP	O
	shown	show	I-VP	O
	to	to	I-VP	O
	be	be	I-VP	O
	sufficient	sufficient	B-ADJP	O
	to	to	B-VP	O
	reconstitute	reconstitute	I-VP	O
	at	at	B-NP	O
	least	least	I-NP	O
	some	some	I-NP	O
	aspects	aspect	I-NP	O
	of	of	B-PP	O
	this	this	B-NP	O
	regulation	regulation	I-NP	O
	in	in	B-PP	O
	non-lymphoid	non-lymphoid	B-NP	O
	cells	cell	I-NP	O
	.	.	O	O

	Different	Different	B-NP	O
	amounts	amount	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	various	various	I-NP	O
	isoforms	isoform	I-NP	O
	are	be	B-VP	O
	present	present	B-ADJP	O
	within	within	B-PP	O
	the	the	B-NP	O
	same	same	I-NP	O
	B-cell	B-cell	I-NP	O
	regardless	regardless	B-ADVP	O
	of	of	B-PP	O
	the	the	B-NP	O
	developmental	developmental	I-NP	O
	stage	stage	I-NP	O
	of	of	B-PP	O
	B-cell	B-cell	B-NP	O
	differentiation	differentiation	I-NP	O
	and	and	O	O
	at	at	B-ADVP	O
	least	least	I-ADVP	O
	some	some	B-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	isoforms	isoform	I-NP	O
	are	be	B-VP	O
	conserved	conserve	I-VP	O
	between	between	B-PP	O
	mouse	mouse	B-NP	O
	and	and	O	O
	humans	human	B-NP	O
	.	.	O	O

	One	One	B-NP	O
	explanation	explanation	I-NP	O
	for	for	B-PP	O
	the	the	B-NP	O
	perpetuation	perpetuation	I-NP	O
	of	of	B-PP	O
	virus	virus	B-NP	O
	infection	infection	I-NP	O
	in	in	B-PP	O
	macrophages	macrophage	B-NP	O
	could	could	B-VP	B-SPECCUE
	be	be	I-VP	O
	sustained	sustain	I-VP	O
	nuclear	nuclear	B-NP	O
	NF-kappa	NF-kappa	I-NP	O
	B	B	I-NP	O
	expression	expression	I-NP	O
	.	.	O	O

	The	The	B-NP	O
	dexamethasone	dexamethasone	I-NP	O
	Kd	Kd	I-NP	O
	was	be	B-VP	O
	2.45	2.45	B-NP	O
	±	Â±	O	O
	0.58	0.58	B-NP	O
	nM	nM	I-NP	O
	-LRB-	(	O	O
	mean	mean	B-NP	O
	±	Â±	I-NP	O
	SEM	SEM	I-NP	O
	,	,	O	O
	n	n	B-NP	O
	=	=	B-VP	O
	6	6	B-NP	O
	-RRB-	)	O	O
	in	in	B-PP	O
	the	the	O	O
	CS	CS	B-NP	O
	group	group	B-NP	O
	and	and	O	O
	1.6	1.6	B-NP	O
	±	Â±	I-NP	O
	0.35	0.35	I-NP	O
	nM	nM	I-NP	O
	-LRB-	(	O	O
	mean	mean	B-NP	O
	±	Â±	I-NP	O
	SEM	SEM	I-NP	O
	,	,	O	O
	n	n	B-NP	O
	=	=	B-VP	O
	6	6	B-NP	O
	-RRB-	)	O	O
	in	in	B-PP	O
	the	the	B-NP	O
	CR	CR	I-NP	O
	group	group	I-NP	O
	of	of	B-PP	O
	patients	patient	B-NP	O
	-LRB-	(	O	O
	p	p	B-NP	O
	=	=	B-VP	O
	0.14	0.14	B-NP	O
	-RRB-	)	O	O
	.	.	O	O

	The	The	B-NP	O
	Ro	Ro	I-NP	O
	in	in	B-PP	O
	the	the	B-NP	O
	CS	CS	I-NP	O
	group	group	I-NP	O
	was	be	B-VP	O
	3,605	3,605	B-NP	O
	±	Â±	I-NP	O
	984	984	I-NP	O
	binding	bind	I-NP	O
	sites	site	I-NP	O
	per	per	B-PP	O
	nucleus	nucleus	B-NP	O
	-LRB-	(	O	O
	mean	mean	B-NP	O
	±	Â±	I-NP	O
	SEM	SEM	I-NP	O
	,	,	O	O
	n	n	B-NP	O
	=	=	B-VP	O
	6	6	B-NP	O
	-RRB-	)	O	O
	and	and	O	O
	4,757	4,757	B-NP	O
	±	Â±	I-NP	O
	692	692	I-NP	O
	binding	bind	I-NP	O
	sites	site	I-NP	O
	per	per	B-PP	O
	nucleus	nucleus	B-NP	O
	-LRB-	(	O	O
	mean	mean	B-NP	O
	±	Â±	I-NP	O
	SEM	SEM	I-NP	O
	,	,	O	O
	n	n	B-NP	O
	=	=	B-VP	O
	6	6	B-NP	O
	-RRB-	)	O	O
	in	in	B-PP	O
	the	the	B-NP	O
	CR	CR	I-NP	O
	group	group	I-NP	O
	-LRB-	(	O	O
	p	p	B-NP	O
	=	=	B-VP	O
	0.23	0.23	B-NP	O
	-RRB-	)	O	O
	.	.	O	O

	GPIIb	GPIIb	B-NP	O
	,	,	O	O
	the	the	B-NP	O
	alpha	alpha	I-NP	O
	subunit	subunit	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	platelet	platelet	I-NP	O
	cytoadhesin	cytoadhesin	I-NP	O
	GPIIb-IIIa	GPIIb-IIIa	I-NP	O
	,	,	O	O
	is	be	B-VP	O
	produced	produce	I-VP	O
	in	in	B-PP	O
	megakaryocytes	megakaryocyte	B-NP	O
	at	at	B-PP	O
	an	an	B-NP	O
	early	early	I-NP	O
	stage	stage	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	differentiation	differentiation	I-NP	O
	,	,	O	O
	whereas	whereas	O	O
	the	the	B-NP	O
	other	other	I-NP	O
	subunit	subunit	I-NP	O
	of	of	B-PP	O
	this	this	B-NP	O
	complex	complex	I-NP	O
	,	,	O	O
	GPIIIa	GPIIIa	B-NP	O
	,	,	O	O
	is	be	B-VP	O
	expressed	express	I-VP	O
	in	in	B-PP	O
	other	other	B-NP	O
	cells	cell	I-NP	O
	.	.	O	O

	One	One	B-NP	O
	region	region	I-NP	O
	,	,	O	O
	centered	center	B-ADJP	O
	at	at	B-PP	O
	-54	-54	B-NP	O
	,	,	O	O
	is	be	B-VP	O
	similar	similar	B-ADJP	O
	to	to	B-PP	O
	a	a	B-NP	O
	nuclear	nuclear	I-NP	O
	factor	factor	I-NP	O
	E1-binding	E1-binding	I-NP	O
	site	site	I-NP	O
	,	,	O	O
	and	and	O	O
	a	a	B-NP	O
	region	region	I-NP	O
	located	located	B-ADJP	O
	at	at	B-PP	O
	position	position	B-NP	O
	-233	-233	I-NP	O
	contains	contain	B-VP	O
	a	a	B-NP	O
	CCAAT	CCAAT	I-NP	O
	motif	motif	I-NP	O
	.	.	O	O

	The	The	B-NP	O
	hormone	hormone	I-NP	O
	receptors	receptor	I-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	primary	primary	I-NP	O
	tumor	tumor	I-NP	O
	were	be	B-VP	O
	known	know	I-VP	O
	in	in	B-PP	O
	15	15	B-NP	O
	-LRB-	(	O	O
	ER	ER	B-NP	O
	-RRB-	)	O	O
	and	and	O	O
	14	14	B-NP	O
	-LRB-	(	O	O
	PR	PR	B-NP	O
	-RRB-	)	O	O
	patients	patient	B-NP	O
	,	,	O	O
	respectively	respectively	B-ADVP	O
	.	.	O	O

	We	We	B-NP	O
	describe	describe	B-VP	O
	a	a	B-NP	O
	slide	slide	I-NP	O
	assay	assay	I-NP	O
	that	that	B-NP	O
	allows	allow	B-VP	O
	the	the	B-NP	O
	demonstration	demonstration	I-NP	O
	of	of	B-PP	O
	antigens	antigen	B-NP	O
	localized	localize	B-VP	O
	in	in	B-PP	O
	the	the	B-NP	O
	nucleus	nucleus	I-NP	O
	from	from	B-PP	O
	isolated	isolate	B-NP	O
	white	white	I-NP	O
	blood	blood	I-NP	O
	cells	cell	I-NP	O
	as	as	B-CONJP	O
	well	well	I-CONJP	O
	as	as	I-CONJP	O
	from	from	B-PP	O
	single	single	B-NP	O
	tumor	tumor	I-NP	O
	cells	cell	I-NP	O
	derived	derive	B-VP	O
	from	from	B-PP	O
	malignant	malignant	B-NP	O
	effusions	effusion	I-NP	O
	.	.	O	O

	With	With	B-PP	O
	the	the	B-NP	O
	antibodies	antibody	I-NP	O
	Ki-67	Ki-67	I-NP	O
	and	and	O	O
	anti-p-145	anti-p-145	B-NP	O
	an	an	B-NP	O
	increased	increase	I-NP	O
	rate	rate	I-NP	O
	of	of	B-PP	O
	nuclear	nuclear	B-NP	O
	and	and	I-NP	O
	nucleolar	nucleolar	I-NP	O
	staining	staining	I-NP	O
	resulted	result	B-VP	O
	in	in	B-PP	O
	cells	cell	B-NP	O
	from	from	B-PP	O
	highly	highly	B-NP	O
	malignant	malignant	I-NP	O
	lymphomas	lymphoma	I-NP	O
	.	.	O	O

	Cells	Cell	B-NP	O
	isolated	isolate	B-VP	O
	from	from	B-PP	O
	the	the	B-NP	O
	blood	blood	I-NP	O
	of	of	B-PP	O
	patients	patient	B-NP	O
	with	with	B-PP	O
	leukemic	leukemic	B-NP	O
	spread	spread	I-NP	O
	of	of	B-PP	O
	lymphomas	lymphoma	B-NP	O
	of	of	B-PP	O
	low	low	B-NP	O
	malignancy	malignancy	I-NP	O
	yielded	yield	B-VP	O
	a	a	B-NP	O
	weak	weak	I-NP	O
	staining	staining	I-NP	O
	comparable	comparable	B-ADJP	O
	to	to	B-PP	O
	that	that	B-NP	O
	of	of	B-PP	O
	normal	normal	B-NP	O
	mesothelial	mesothelial	I-NP	O
	cells	cell	I-NP	O
	from	from	B-PP	O
	non-tumorous	non-tumorous	B-NP	O
	cavity	cavity	I-NP	O
	fluids	fluid	I-NP	O
	.	.	O	O

	ER	ER	B-NP	O
	was	be	B-VP	O
	positive	positive	B-ADJP	O
	in	in	B-PP	O
	13	13	B-NP	O
	and	and	O	O
	PR	PR	B-NP	O
	was	be	B-VP	O
	positive	positive	B-ADJP	O
	in	in	B-PP	O
	12	12	B-NP	O
	of	of	B-PP	O
	the	the	B-NP	O
	20	20	I-NP	O
	samples	sample	I-NP	O
	.	.	O	O
